ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,149, issued on March 31, was assigned to ADVAGENE BIOPHARMA Co. LTD. (Taipei City, Taiwan).
"Method of modulating mucosal immunogenicity" was invented by Yu-Shen Hsu (Taipei City, Taiwan), Mingi Chang (Taipei City, Taiwan) and Ssu-Wei Kang (Taipei City, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a novel method for modulating mucosal immune response, comprising administering an antigen to a mucosal site of a subject in need thereof, and administering an immunomodulator to a different anatomical mucosal site of said subject. The antigen may be administered to sublingual mucosa and the immunomodulator may be ...